REXIS BIOTECH ANNOUNCES STRATEGIC PARTNERSHIP WITH 3CHI & WEFUNDER CROWDFUNDING EQUITY RAISE
Dover Delaware – July 13, 2023 – Rexis Biotech Inc. (“REXIS”) is delighted to announce its continued growth and expansion into new markets through a strategic partnership with 3Chi, Inc.. This is one of several licensing agreements that Rexis is continuing to announce. 3Chi is the largest finished goods producer in the hemp derived marketplace […]
